BioTuesdays

Tag - LNTH

SVB Leerink starts Lantheus at OP; PT $24

SVB Leerink launched coverage of Lantheus Holdings (NASDAQ:LNTH) with an “outperform” rating and $24 price target. The stock closed at $16.27 on Jan. 29. Lantheus is a leading player in diagnostic nuclear medicine...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.